inThought Announces the Promotion of Dr. Amanda Weyerbacher to Executive VP

Your ads will be inserted here by

Easy Plugin for AdSense.

Please go to the plugin admin page to
Paste your ad code OR
Suppress this ad slot.

inThought Announces the Promotion of Dr. Amanda Weyerbacher to Executive VP

PR Newswire

Dr. Weyerbacher’s new leadership role is critical to fast-turnaround, high-impact strategy engagements

ORLANDO, Fla., March 31, 2026 /PRNewswire/ — inThought Research Inc., a leading provider of decision support for the life sciences industry, today announced the promotion of Dr. Amanda Weyerbacher from Director of Research to Executive Vice President of Projects and Operations. In this new role, Dr. Weyerbacher will lead project execution and oversee operational rigor. She will work with project leaders to maintain project quality and compliance, ensuring each client receives inThought’s highest calibre decision support.

https://mma.prnewswire.com/media/2946205/inThought_Research_Logo.jpg

Ben Weintraub, President of inThought commented, “Dr. Weyerbacher is the key to inThought’s ability to successfully execute opportunity assessments, licensing due diligence, launch planning, competitive positioning, life cycle management, and other fast-paced strategy projects.”

Dr. Weyerbacher joined inThought in 2015 and has served as Director of Research since 2023. As a Senior Principal, she has led projects in oncology, immunology, and respiratory disease. Prior to inThought, she was a Senior Scientist at L’Oréal. She holds a PhD in Pharmacology from Weill Cornell Medical College and is a graduate of Skidmore College. Dr. Weyerbacher notes, “I look forward to ensuring that inThought’s extraordinary analysts have the tools they need to deliver first class strategic advice to all our clients.”

Your ads will be inserted here by

Easy Plugin for AdSense.

Please go to the plugin admin page to
Paste your ad code OR
Suppress this ad slot.

About inThought

inThought Research empowers biopharma leaders with comprehensive strategic insights. We combine Wall Street financial acumen and swiftness, scientific and medical expertise, and advanced AI analytics to navigate the complex landscape of drug development. Our multidisciplinary approach integrates clinical data, market analytics, and stakeholder perspectives. Through inThought Labs, we combine cutting-edge technology with the work of our subject matter experts to transform complex data into actionable intelligence. For more information, please visit www.inthought.com.

Contact information Doug Foster, Chief Operating Officer (508) 414-9819 [email protected]

Logo – https://mma.prnewswire.com/media/2946205/inThought_Research_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/inthought-announces-the-promotion-of-dr-amanda-weyerbacher-to-executive-vp-302729305.html

contador

Publicidad